Correction: Within-Trial Cost-Effectiveness Analysis of a Family-Based Structured Lifestyle Modification Intervention Program for Cardiovascular Risk Reduction: Results from the PROLIFIC Trial
Ashis Samuel John, Sanjay Ganapathi, Sivadasanpillai Harikrishnan, Thoniparambil Ravindranathanpillai Lekha, Antony Stanley, Biju Soman, Thekkumkara Surendran Anish, Rujuta Hadaye, Jerin Jose Cherian, Nikhil Tandon, Dorairaj Prabhakaran, Panniyammakal Jeemon
TL;DR
This paper corrects a previously published study on the cost-effectiveness of a family-based lifestyle program to reduce cardiovascular risk.
Contribution
The correction addresses errors in the original publication to ensure accuracy in the findings.
Findings
The correction clarifies data or methodology in the original study.
It ensures the reported cost-effectiveness results are accurate and reliable.
Abstract
This article details a correction to: John, A.S., Ganapathi, S., Harikrishnan, S., Lekha, T.R., Stanley, A., Soman, B., Anish, T.S., Hadaye, R., Cherian, J.J., Tandon, N., Prabhakaran, D. and Jeemon, P. (2025) ‘Within-Trial Cost-Effectiveness Analysis of a Family-Based Structured Lifestyle Modification Intervention Program for Cardiovascular Risk Reduction: Results from the PROLIFIC Trial’, Global Heart, 20(1), p. 65. Available at: https://doi.org/10.5334/gh.1450.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealth Promotion and Cardiovascular Prevention · Cardiac Health and Mental Health · Heart Failure Treatment and Management